Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

British Journal of Cancer

Volumn 85, Issue 6, 2001, Pages 881-890

  Giatromanolaki, A ^a   Koukourakis, M I ^a   Sivridis, E ^a   Turley, H ^b   Talks, K ^b   Pezzella, F ^b   Gatter, K C ^b   Harris, A L ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Hypoxia inducible factors; Non small cell lung cancer; Prognosis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; METAPLASIA; PRIORITY JOURNAL; PROGNOSIS; TRANSCRIPTION REGULATION; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0035860147     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2018     Document Type: Article

References (48)

1. Expression of hypoxia-inducible factor-1α: A novel predictive and prognostic parameter in the radiotherapy of orop haryngeal cancer
2. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
3. The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target
4. Levels of hypoxia-inducible factor-1α during breast carcinogenesis
5. Vascular endothelial growth factor as a marker of tumor endothelium
6. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
7. 2 sensing
8. Keratinocyte induced chemotaxis in the pathogenesis of Paget's disease of the breast
9. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
10. Isoenzyme specific regulation of genes involved in energy metabolism by hypoxia: Similarities with the regulation of erythropoietin
11. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development
12. Endothelial cell responses to hypoxic stress
13. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
14. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor I
15. Oxygen distribution in squamous cell carcinoma metastases and its relationship in outcome of radiation therapy
16. Non small cell lung cancer: C-erbB-2 correlates with low angiogenesis and poor prognosis
17. Vascular endothelial growth factor, wild-type p53 and angiogenesis in early operable non-small cell lung cancer
18. Intratumoral angiogenesis: A new prognostic indicator for stage I endometrial adenocarcinomas?
19. Co-expression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggets co-activation of angiogenic and migratory pathways
20. Regulation of the erythropoietin gene: Evidence that oxygen sensor is a heme protein
21. Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes
22. The influence of oxygen-tension and pH on the expression of platelet-derived endothelial cell growth factor thymidine phosphorylase in human breast-tumor cells grown in vitro and in vivo
23. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3alpha
24. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its a subunit
25. 2-dependent degradation domain via the ubiquitine-proteasome pathway
26. V-SRC induces expression of hypoxia inducible factor I (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase-1: Involvement of HIF-1 in tumor progression
27. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer
28. Potential role of bcl-2 as a suppressor of tumour angiogenesis in non small cell lung cancer
29. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non small cell lung cancer. Impact on neoangiogenesis and survival
30. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small cell lung cancer
31. Prognostic and pathologic comparison of VEGF/KDR activated microvessel density (aMVD) vs. CD31 standard MVD (sMVD) in non-small cell lung cancer
32. Hypoxia-inducible factor I modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
33. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
34. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Haras-transformed cells through a hypoxia inducible factor-1 transcriptional element
35. Hypoxia-induced protein binding to O2-responsive sequences on the tyrosine hydroxylase gene
36. Hypoxia increases human keratinocyte motility on connective tissue
37. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1
38. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
39. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene
40. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells
41. The expression and distribution of the hypoxia inducible factors HIF- 1á and HIF-2a in normal human tissues, cancers and tumor associated macrophages
42. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
43. Ki-67 immunostaining and survival in operable lung cancer
44. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer
45. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
46. Expression of hypoxia-inducible factor I alpha in brain tumours: Association with angiogenesis, invasion, and progression
47. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
48. Loss of PTEN facilitates HIF-1-mediated gene expression